While further investigation is required, these data do suggest that CBX2 may inhibit the expression of the tumour suppressor RBL2 in multiple cancer types and, therefore, may repress RBL2-DREAM complex activity across multiple malignancies to promote cell growth. This evidence concerns the gene KCNIP3 and cancer.